JUL 03, 2019 09:30 AM PDT

Noninvasive New Test Can Diagnose Bowel Disease

WRITTEN BY: Carmen Leitch

Our gut is very important to our health. It hosts a vast community of microbes that influence digestion, the immune system, and the development of many diseases, some of which are becoming more common. Inflammatory bowel disease (IBD) is one of those disorders. In 2015, three million people in the US and 250,000 people in Britain were diagnosed with IBD. Now researchers have created a diagnostic tool that can easily and non-invasively assess gut function. The work has been reported in Experimental Physiology.

IBD is a broad term that describes chronic gut inflammation and includes several conditions, including Crohn's disease and ulcerative colitis. Symptoms include serious abdominal discomfort, diarrhea, reduced appetite, and fatigue. It is often diagnosed using procedures like colonoscopies or endoscopies that enable clinicians to examine the intestinal tract visually.

The intestinal tract has a very special lining, which has to be able to both soak up the nutrients we need from the food we ingest while keeping undesirable inflammatory molecules and pathogenic microbes from getting in. If this barrier gets damaged, it can cause serious health problems. In intestinal diseases like IBD, the intestinal lining is compromised, and chemicals produced by bacteria, or bacteria themselves, pass through the barrier and into the blood in a phenomenon often called leaky gut.

In this study, scientists have created a new way to assess gut function that only requires a milliliter (about one-fifth of a teaspoon) of blood and stool. The test focuses on short‐chain fatty acids (SCFA) that are made by bacteria. Using a rodent model and clinical samples from children with and without IBD, the researchers ratioed the levels of several types of SCFAs in the blood to the levels in the stool.

The researchers reported that their rodent model and patients showed that IBD causes an increase in the blood‐to‐stool ratio of SCFA. They suggested that SCFAs are penetrating to the blood more frequently in IBD cases.

This test doesn't require the preparation or anesthesia that a colonoscopy necessitates. It also can analyze whether the gut is leaky even if the lining doesn't appear damaged.

An early diagnosis could help keep a gut disorder from getting worse and causing other problems, as well as helping patients sooner. It may also be useful in assessing food allergies and celiac disease, but that will have to be confirmed with additional testing.

"This may be a very important tool for diagnosis and treatment of gut and other diseases, using the leaky gut as a marker for disease, as well as a potential target for treatment," noted the senior author of the study Marcin Ufnal.


Sources: AAAS/Eurekalert! via The Physiological Society, Experimental Physiology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 18, 2020
Microbiology
JAN 18, 2020
Unusual Fungi Found in Marine Environments
Fungal colonies were cultured from samples collected in various marine environments. Image by: Lorna M.Y. Mitchison-Field...
JAN 18, 2020
Microbiology
JAN 18, 2020
The Mechanism of Lysostaphin, a MRSA-Killing Enzyme, is Revealed
This study can help inform the development of new treatments for antibiotic-resistant microbes....
JAN 18, 2020
Microbiology
JAN 18, 2020
Probiotics Linked to Bloodstream Infections in ICU Patients
Probiotics, which are live microbes, are intended to improve human health, and they are sometimes given to intensive care unit patients of all ages....
JAN 18, 2020
Genetics & Genomics
JAN 18, 2020
Engineering a Better Viral Delivery System for Gene Therapy
To send gene therapy to diseased cells, scientists have turned to adeno-associated viruses (AAVs) to act as a delivery system....
JAN 18, 2020
Immunology
JAN 18, 2020
T Cell Subset Uniquely Equipped to Target IBD
A specialized form of T cell emerges as a new focus for gastrointestinal health research, specifically in the context of inflammatory bowel disease (IBD) f...
JAN 18, 2020
Drug Discovery & Development
JAN 18, 2020
Designing Drugs To Fight off C. Diff Infections
A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in th...
Loading Comments...